Funding profile · Industrial biotechnology
Industrial Microbes
Ten years of federal grant money, a Defense Department award to plan a factory, a seed round announced in November 2024, and no Form D on file with the SEC under either company name.
Data as of September 23, 2026. Company-reported figures are labeled.
Rounds at a glance
| When | Round | Amount | Investors | Source |
|---|---|---|---|---|
| 2015 | Y Combinator | Not disclosed | Y Combinator | Press report |
| 2015 to 2016 | SBIR Phase I, three agencies | $179,999 NSF; $150,000 DOE; $100,000 USDA | NSF, DOE, USDA | Award record |
| 2017 to 2019 | EPA SBIR Phase II, contract EP-D-17-020 | $300,000 | EPA | Award record |
| Oct 2019 | DOE SBIR Phase II with Opus 12 | $1.0M announced; listed at $1.2M | DOE | Award record |
| By 2024 | BioMADE project, Sustainable Carbon Fiber from Waste | Per project amount not broken out | BioMADE, with Georgia Tech and FERMWORX | Consortium listing |
| Aug 2024 | DoD Distributed Bioindustrial Manufacturing Program | $1.55M | US Department of Defense, via the Defense Industrial Base Consortium | Award record |
| Nov 2024 | Seed, first close | Round size not disclosed; total investment stated as more than $10M | First Bight Ventures (lead), Universal Materials Incubator Co. | Company release |
| Sep 2025 | BioMADE-backed scale-up project | Not disclosed | BioMADE | Company release |
What the filings show
Industrial Microbes, Inc. · no Form D on file · checked Sep 23, 2026
- Registrant search
- EDGAR company search for Industrial Microbes and for iMicrobes returns no matching companies
- Full text search
- 0 hits for the phrase Industrial Microbes across Form D filings
- Reported first close
- Nov 19, 2024
- Form D deadline
- Within 15 days of first sale, for an offering made under Regulation D
- Related vehicles
- No pooled investment fund or SPV named for the company appears on EDGAR
- Reading
- Either the round was sold under Section 4(a)(2) without relying on Regulation D, or it was filed under a name that does not contain the words Industrial Microbes
- Filing
- SEC EDGAR, no CIK assigned
Reading the filings
- There is nothing to read, and that is the finding.A company that announced a first close in November 2024 would owe a Form D within 15 days of first sale if the offering used Regulation D. None exists. Companies that sell under Section 4(a)(2) file nothing, so the absence is not evidence that no money moved, but it does mean the round size, investor count and average check are unverifiable from the public record.
- At least a third of the money is public.SBIR listings across NSF, EPA, DOE and USDA come to about $2.0 million, and the 2024 Defense Department planning award adds $1.55 million. That is roughly $3.55 million of federal money against a company-reported total of more than $10 million, or about 35%. The company has not said whether its $10 million figure includes grants.
- Nine years to a seed round.The company dates to 2014 and went through Y Combinator in 2015. The first close of a round labelled seed came on November 19, 2024. Federal awards, not equity, carried the first decade.
- The grant figure does not reconcile.In October 2019 the company said it had raised more than $3.5 million in grant funding to date. SBIR awards on the record through 2019 total $1,929,999, or $2,029,999 if the higher EPA Phase II figure listed by inKnowVation is used instead of the $300,000 shown on SBIR.gov. That leaves roughly $1.5 million of stated grant money with no matching public award record.
- The largest single check is a government one.The $1.55 million DBIMP award is the biggest amount attached to this company anywhere in the public record. No private round amount has ever been disclosed, only a cumulative total. The DBIMP structure matters more than the size: planning awardees can negotiate for follow-on access to up to $100 million to build a facility.
- Two investors, no valuation, no board disclosure.First Bight Ventures led and Universal Materials Incubator Co. participated. No other investor has been named, no valuation reported, and no board composition disclosed. With no Form D, there is no related persons list to check any of it against.
Commercial signals
| Signal | Detail | Source type |
|---|---|---|
| Federal validation | 300 liter P3HP production at DOE’s Agile BioFoundry and ABPDU, reported Oct 2024, with lab metrics preserved at scale. | Public record |
| Scale | 2 liter to 1,500 liter reactors and 20 kilogram batches, announced Sep 2025 with BioMADE backing and the Integrated Bioprocessing Research Lab. | Company-stated |
| Facility | Planning work funded for a commercial-scale ethanol to acrylic acid plant. Site undetermined as of the Aug 2024 announcement. | Public record |
| Customers | Four commercial partners claimed on the about page; multiple letters of intent claimed in Sep 2025. None named. | Company-stated |
| Intellectual property | Six granted US patents and three published applications on Justia. Company states 22 patents in Nov 2024 and 23 in Sep 2025. | Claim exceeds the US record |
| Revenue | No revenue figure published. No offtake agreement named. | Not found |
What to watch
- A first Form D, or a Series A announcement with a named lead and a stated amount.
- Whether the DBIMP planning award converts to a construction award and a named site.
- Conversion of a letter of intent into a supply agreement with a named counterparty.
- Any disclosure of whether the more than $10 million total counts federal grant money.
The Industrial Microbes story on Healthcare DiscoveryHealthcare Discovery
Related companies
Sources
- Public recordEDGAR company search and Form D full text search for Industrial Microbes and iMicrobes
- Public recordNSF award 1520425, SBIR Phase I
- Public recordSBIR award 160064, EPA Phase II, contract EP-D-17-020
- Public recordDoD Releases Five Awards for Distributed Bioindustrial Manufacturing Program
- Public recordDepartment of Energy’s Agile BioFoundry and ABPDU Partner with Industrial Microbes
- Public recordCompany profile with SBIR award history by agency, Industrial Microbes Inc
- Public recordPatents assigned to INDUSTRIAL MICROBES, INC.
- IndependentiMicrobes closes seed round of $10M to transform ethanol and methane into biochemicals
- IndependentIndustrial Microbes secures $10 M in seed funding to scale sustainable biobased materials
- Independent17 New BioMADE Projects Aim to Boost U.S. Bioeconomy
- CompanyIndustrial Microbes announces seed round funding
- CompanyIndustrial Microbes and Opus 12 Awarded $1M to Turn Waste Gas into Valuable Chemicals
Compiled from SEC, NSF, EPA, DOE, USDA and Department of Defense public records and published reports as of September 23, 2026. Form D notices report offerings under Regulation D; no such notice exists for this company, and offerings sold under Section 4(a)(2) require none. Healthcare Venture Capital Fund holds no position in Industrial Microbes. This page is not an offer to sell or a recommendation to buy any security.
